Vayacog® has been studied in a multi-center, double-blind, placebo controlled, randomized clinical study that was published in a peer-reviewed journal publication.

EFFICACY

 

SAFETY

 

  • Clinically proven to be safe and well tolerated
  • No known drug contraindications, however Vayacog® could potentially interact with cholinergic or anticholinergic medications

Our patented PS-Omega-3 structure was clinically studied and shown to be the only formulation of Omega-3 (versus fish oil, phosphatidylserine and fish oil taken with phosphatidylserine) to increase the bioavailability of Omega-3 in the brain, across the blood brain barrier.

BIOAVAILIBILITY

IN ANIMAL MODEL, PS-OMEGA-3 SIGNIFICANTLY INCREASED DHA BIOAVAILABILITY TO THE BRAIN

Significant increase of 42% in DHA bioavailability in the brain versus control